Hi [[ session.user.profile.firstName ]]

Cause to cure: ESG engagement and research on food labelling and drug pricing

Investors often have mixed views on the benefits of ESG engagement, especially within Big Industry sectors. As long-term stewards of client’s capital, our goal is to provide meaningful insights on our engagements with the aim of demonstrating how ESG research is good not only for investors in the form of improved stock prices, but how engagement may also prove beneficial for those companies willing to express change within their business models. This webinar will focus on the ESG Team’s engagement research within the Pharmaceuticals and Consumer Staples -- two critically important consumer-driven global industries.
Recorded Nov 30 2016 38 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Jessica Ground, Global Head of Stewardship, Elly Irving, ESG Analyst, and Seema Suchak, ESG Analyst, each with Schroders
Presentation preview: Cause to cure: ESG engagement and research on food labelling and drug pricing
  • Channel
  • Channel profile
Hartford Schroders Funds
Hartford Schroders Mutual Funds Content

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Cause to cure: ESG engagement and research on food labelling and drug pricing
  • Live at: Nov 30 2016 4:00 pm
  • Presented by: Jessica Ground, Global Head of Stewardship, Elly Irving, ESG Analyst, and Seema Suchak, ESG Analyst, each with Schroders
  • From:
Your email has been sent.
or close